Profound Medical Corp faces significant challenges as its stock drops sharply.
Profound Medical Corp (PRN.TO) is seeing a notable decline in its stock price, down 8.11% in today’s trading session. This drop raises concerns among investors about the company's current trajectory and future prospects.
Advertisement
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeMarket cap
$407.34M
52W high
$12.40
52W low
$5.23
1W change
+8.19%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 125.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+125.5% Upside
Current Price
C$11.10
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
56.0%
Annualized
90-Day Vol
53.7%
Annualized
Trend (90d)
+49.8%
Annualized drift
90d Mean
C$13.26
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$11.78 | C$9.71 – C$14.29 |
| 60 trading days | C$12.50 | C$9.51 – C$16.42 |
| 90 trading days | C$13.26 | C$9.49 – C$18.53 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious as Profound Medical struggles to maintain confidence amid recent setbacks.
Stock Down 8.11% Today
Profound Medical's market cap now stands at approximately CA$407 million following today's significant drop.
Bull case
Despite today’s downturn, the company has innovative technologies that could drive future growth if they can successfully navigate current challenges.
Bear case
The failure of the CAPTAIN trial to meet its primary endpoint raises serious questions about the viability of Profound's current product offerings, which could lead to further declines.
Recent Performance Overview
Advertisement
Profound Medical Corp's stock has seen a sharp decline today, dropping 8.11% to close at CA$10.20. This downturn follows a lack of positive news and investor uncertainty stemming from the recent CAPTAIN trial results.
Impact of CAPTAIN Trial Results
The recent announcement that the CAPTAIN trial did not meet its primary endpoint has negatively affected investor sentiment. This news has raised concerns about the effectiveness of Profound Medical's key products, contributing to today's stock decline.
Looking Ahead
As Profound Medical prepares to release its second-quarter financial results on August 6, investors will be closely watching for any signs of recovery or further challenges. The upcoming conference call will be crucial for understanding the company's strategy moving forward.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
